General MedicationsINJECTIONStandard
YERVOY
IPILIMUMAB
Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview YERVOY is listed in Drugs@FDA under application 125377 (BLA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient IPILIMUMAB Form and strength INJECTABLE; INJECTION - 3MG Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2025-05-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview YERVOY is listed in Drugs@FDA under application 125377 (BLA). Review priority: PRIORITY Marketing status: Prescription Active ingredient IPILIMUMAB Form and strength INJECTABLE; INJECTION - 3MG Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2025-05-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.